The range of expression levels of SAA4 and VDBP was wide in rheumatoid arthritis patients, although the expression of these biomarkers was higher in the rheumatoid arthritis patients than in the control group (Figure 4). The gene discussed is GC; the disease is rheumatoid arthritis.